Biology subjects

Boyko, V.

Publications and source records attributed to Boyko, V..

5 recordsLinked to original sources

bioRxiv2025

Integrated Approach to Investigate Magnetite Cycle in Marine Methanic Sediments

Magnetite (Fe3O4), a ubiquitous sedimentary iron mineral, is crucial for paleomagnetic records preservation. However, reactive ferric iron minerals, including magnetite, can undergo reduction in aquatic sediments above and within the sulfidic zone and at the Sulfate-Methane Transition Zone (SMTZ), resulting in the production of dissolved ferrous iron. Partial reoxidation of the reduced iron at the oxic-anoxic interface can lead to authigenic magnetite precipitation. Yet, magnetite persistence and behavior in deeper methanic sediments have remained poorly understood. Here we explore magnetite dynamics in different sub-methanic zones (deeper, middle and upper) of Mediterranean continental shelf sediments, including the potential for its authigenic precipitation. Sequential extractions revealed increasing magnetite concentrations accompanied by low-temperature magnetization (Verwey transition). First-order reversal curve (FORC) analyses supported nanoscale authigenic magnetite presence. The results highlight a net increase in single-domain magnetite in the middle methanic zone with declines in the upper and deeper zones. Microbial analyses pointed to iron reduction throughout the methanic zone, alongside potential precipitation of magnetite and a decline in methanogenesis functional genes. Sediment incubations with spiked 57Fe-ferrihydrite showed gross precipitation of isotopically enriched 57Fe-magnetite in the upper methanic zone. Our combined findings distinguish between gross and net magnetite precipitation, suggesting authigenic magnetite formation within the methanic zone, with reshaping and smoothing of the original magnetic signal. They also emphasize the limitations of relying on a single-method approach to unravel such complex processes. We propose that the methanic zone plays a critical role in the early diagenesis of magnetic minerals, driven by dynamic cycles of magnetite dissolution and authigenic precipitation.

biochemistry↗

bioRxiv2021

ERα-LBD, a novel isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance

Estrogen receptor alpha (ER) drives mammary gland development and breast cancer (BC) growth through an evolutionarily conserved linkage of DNA binding and hormone activation functions. Therapeutic targeting of the hormone binding pocket is a widely utilized and successful strategy for breast cancer prevention and treatment. However, resistance to this endocrine therapy is frequently encountered and may occur through bypass or reactivation of ER-regulated transcriptional programs. We now identify the induction of a novel ER isoform, ER-LBD, that is encoded by an alternative ESR1 transcript and lacks the activation function and DNA binding domains. Despite lacking the transcriptional activity, ER-LBD is found to promote breast cancer growth and resistance to the ER antagonist fulvestrant. ER-LBD is predominantly localized to the cytoplasm and mitochondria of BC cells and leads to enhanced glycolysis, respiration and stem-like features. Intriguingly, ER-LBD expression and function does not appear to be restricted to cancers that express full length ER but also promotes growth of triple negative breast cancers and ER-LBD transcript (ESR1-LBD) is also present in BC samples from both ER(+) and ER(-) human tumors. These findings point to ER-LBD as a potential mediator of breast cancer progression and therapy resistance. SIGNIFICANCE STATEMENTEndocrine resistant and metastatic breast cancer (BC) is a clinically significant problem. Our study of fulvestrant resistant cancer cells led to the discovery of a novel ER isoform which we call ER-LBD. Encoded by a truncated transcript variant (ESR1-LBD) and lacking the N-terminal domains (activation of transcription and DNA binding), ER-LBD displays a unique role in BC tumorigenesis and progression by mechanisms that may involve metabolic and cell growth advantages, stemness and therapy resistance. Importantly, ESR1-LBD is preferentially expressed in human breast tumor tissues and may be used as prognostic marker in BC.

cancer biology↗

bioRxiv2020

RNAseq analysis of rodent spaceflight experiments is confounded by sample collection techniques

To understand the physiological changes that occur in response to spaceflight, mice are transported to the International Space Station (ISS) and housed for variable periods of time before euthanasia on-orbit or return to Earth. Sample collection under such difficult conditions introduces confounding factors that need to be identified and addressed. We found large changes in the transcriptome of mouse tissues dissected and preserved on-orbit compared to tissues from mice euthanized on-orbit, preserved, and dissected after return to Earth. Changes due to preservation method eclipsed those between flight and ground samples making it difficult to identify spaceflight-specific changes. Follow-on experiments to interrogate the roles of euthanasia methods, tissue and carcass preservation protocols, and library preparation methods suggested that differences due to preservation protocols are exacerbated when coupled with polyA selection. This has important implications for the interpretation of existing datasets and the design of future experiments.

systems biology↗

bioRxiv2019

Centrioles control the capacity, but not the specificity, of cytotoxic T cell killing

Immunological synapse formation between cytotoxic T lymphocytes (CTLs) and the target cells they aim to destroy is accompanied by reorientation of the CTL centrosome to a position beneath the synaptic membrane. Centrosome polarization is thought to enhance the potency and specificity of killing by driving lytic granule fusion at the synapse and thereby the release of perforin and granzymes toward the target cell. To test this model, we employed a genetic strategy to delete centrioles, the core structural components of the centrosome. Centriole deletion altered microtubule architecture, as expected, but surprisingly had no effect on lytic granule polarization and directional secretion. Nevertheless, CTLs lacking centrioles did display substantially reduced killing potential, which was associated with defects in both lytic granule biogenesis and synaptic actin remodeling. These results reveal an unexpected role for the intact centrosome in controlling the capacity, but not the specificity, of cytotoxic killing.

immunology↗

bioRxiv2018

Interfacial actin protrusions mechanically potentiate killing by cytotoxic T cells

Cytotoxic T lymphocytes (CTLs) kill by forming immunological synapses with target cells and secreting toxic proteases and the pore forming protein perforin into the intercellular space. Immunological synapses are highly dynamic structures that potentiate perforin activity by applying mechanical force against the target cell. Here, we employed high-resolution imaging and microfabrication to investigate how CTLs exert synaptic forces and coordinate their mechanical output with perforin secretion. Using micropatterned stimulatory substrates that enable synapse growth in three dimensions, we found that perforin release occurs at the base of actin-rich protrusions that extend from central and intermediate locations within the synapse. These protrusions, which depended on the cytoskeletal regulator WASP and the Arp2/3 actin nucleation complex, were required for synaptic force exertion and efficient killing. They also mediated physical distortion of the target cell surface during CTL-target cell interactions. Our results reveal the mechanical basis of cellular cytotoxicity and highlight the functional importance of dynamic, three-dimensional architecture in immune cell-cell interfaces.\n\nOne sentence summaryCytotoxic T lymphocytes use F-actin-rich protrusions at the immunological synapse to potentiate perforin-and granzyme-mediated target cell killing.

immunology↗